Abstract

Prasindini Sanam*, Soumya Puranam, Aradyula Mahimardhini, Haveela Rayapati and Chitram Akhila

ABSTRACT

The significance of inventive drug delivery methods in augmenting treatment effectiveness and patient results has been brought to light by the latest developments in anticancer therapy. The substantial advancements in liposomal and nanoparticle drug delivery methods for the treatment of cancer are the main topic of this study. Liposomal delivery methods offer enhanced bioavailability, stability, and controlled medication release by encapsulating medicinal substances in lipid bilayer vesicles. Systems for delivering nanoparticles, which are made of different materials including metals, polymers, and lipids, allow for more accurate targeting and better penetration of cancer cells. We offer a thorough examination of these delivery methods' mechanisms of action, significant developments, and therapeutic uses. Their relative benefits in terms of effectiveness, security, and patient outcomes are highlighted by the comparative analysis. The article also discusses the technological, biological, and regulatory difficulties that these technologies present. Lastly, we look at potential future developments, such as new technologies, approaches to customized medicine, and the use of artificial intelligence to improve medication delivery. This thorough analysis highlights the revolutionary potential of liposomal and nanoparticle drug delivery technologies in promoting anticancer treatment, providing information on their present and possible futures in the oncology area.